113 related articles for article (PubMed ID: 12297387)
1. Immune response to an indigenously developed hepatitis-B (Shanvac-B) vaccine in a tribal community of India.
Murhekar MV; Murhekar KM; Arankalle VA; Sehgal SC
Vaccine; 2002 Oct; 20(29-30):3431-5. PubMed ID: 12297387
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B vaccination in a hyper-endemic tribal community from India: assessment after three years.
Murhekar MV; Murhekar KM; Sehgal SC
Vaccine; 2004 Dec; 23(3):399-403. PubMed ID: 15530686
[TBL] [Abstract][Full Text] [Related]
3. Status of hepatitis B infection - a decade after hepatitis B vaccination of susceptible Nicobarese, an indigenous tribe of Andaman & Nicobar (A&N) islands with high hepatitis B endemicity.
Bhattacharya H; Bhattacharya D; Ghosal SR; Roy S; Sugunan AP
Indian J Med Res; 2015 May; 141(5):653-61. PubMed ID: 26139785
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of hepatitis B virus infection among the tribes of Andaman and Nicobar Islands, India.
Murhekar MV; Murhekar KM; Sehgal SC
Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):729-34. PubMed ID: 18565560
[TBL] [Abstract][Full Text] [Related]
5. Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India.
Velu V; Nandakumar S; Shanmugam S; Jadhav SS; Kulkarni PS; Thyagarajan SP
World J Gastroenterol; 2007 Jun; 13(22):3084-9. PubMed ID: 17589924
[TBL] [Abstract][Full Text] [Related]
6. Clinical safety and efficacy of first indigenous recombinant hepatitis B vaccine.
Kumar A; Joshi N; Sreenivas DV; Palan S; Nagarjuna Kumar YR
J Assoc Physicians India; 1998 Jul; 46(7):620-2. PubMed ID: 12152846
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of hepatitis B infection among the Nicobarese--a mongoloid tribe of the Andaman and Nicobar Islands, India.
Murhekar MV; Murhekar KM; Arankalle VA; Sehgal SC
Epidemiol Infect; 2002 Jun; 128(3):465-71. PubMed ID: 12113491
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hepatitis B infection among the primitive tribes of Andaman & Nicobar Islands.
Murhekar MV; Murhekar KM; Das D; Arankalle VA; Sehgal SC
Indian J Med Res; 2000 Jun; 111():199-203. PubMed ID: 10969487
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.
Losonsky GA; Wasserman SS; Stephens I; Mahoney F; Armstrong P; Gumpper K; Dulkerian S; West DJ; Gewolb IH
Pediatrics; 1999 Feb; 103(2):E14. PubMed ID: 9925860
[TBL] [Abstract][Full Text] [Related]
10. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
[TBL] [Abstract][Full Text] [Related]
11. Immune response to an indigenously developed r-hepatitis B vaccine in mixed population: study of an accelerated vaccination schedule.
Chowdhury A; Santra A; Habibullah CM; Khan AA; Karunakaramaiah J; Kishore TS; Raju AV; Lahiri S
World J Gastroenterol; 2005 Feb; 11(7):1037-9. PubMed ID: 15742410
[TBL] [Abstract][Full Text] [Related]
12. Early and long term anamnestic response to HBV booster dose among fully vaccinated Egyptian children during infancy.
Salama II; Sami SM; Said ZN; Salama SI; Rabah TM; Abdel-Latif GA; Elmosalami DM; Saleh RM; Abdel Mohsin AM; Metwally AM; Hassanin AI; Emam HM; Hemida SA; Elserougy SM; Shaaban FA; Fouad WA; Mohsen A; El-Sayed MH
Vaccine; 2018 Apr; 36(15):2005-2011. PubMed ID: 29530634
[TBL] [Abstract][Full Text] [Related]
13. Duration of protection after infant hepatitis B vaccination series.
Middleman AB; Baker CJ; Kozinetz CA; Kamili S; Nguyen C; Hu DJ; Spradling PR
Pediatrics; 2014 Jun; 133(6):e1500-7. PubMed ID: 24843060
[TBL] [Abstract][Full Text] [Related]
14. Seroepidemiology of hepatitis B infection among tribal school children in Andaman and Nicobar Islands, India.
Murhekar MV; Murhekar KM; Sehgal SC
Ann Trop Paediatr; 2004 Mar; 24(1):85-8. PubMed ID: 15005972
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and reactogenicity of a combined high dose hepatitis A and hepatitis B vaccine, compared to that of Twinrix in healthy Indian children.
Guptan RC; Thakur V; Safary A; Sarin SK
Vaccine; 2002 May; 20(16):2102-6. PubMed ID: 11972979
[TBL] [Abstract][Full Text] [Related]
16. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of mutations in basal core promoter and precore region of hepatitis B virus in vaccinated and nonvaccinated individuals of the aboriginal Nicobarese tribe of Car Nicobar Island, India.
Bhattacharya H; Bhattacharya D; Nagarajan M; Reesu R; Roy S; Attayur PS
Intervirology; 2014; 57(6):357-64. PubMed ID: 25323975
[TBL] [Abstract][Full Text] [Related]
18. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
Avdicova M; Crasta PD; Hardt K; Kovac M
Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
[TBL] [Abstract][Full Text] [Related]
19. [A study on the effectiveness of hepatitis B vaccine among the vaccinated population].
Wang C; Li D
Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Feb; 19(1):43-6. PubMed ID: 10322708
[TBL] [Abstract][Full Text] [Related]
20. [Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine].
Xia G; Jia Z; Yan T; Li R; Liu H; Xu Z; Cao H; Liu C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):146-9. PubMed ID: 12196826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
